• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Chemoembolization With Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma.

作者信息

Dasse Kathy Diener, Lander Michael J, Novelli Paula M

机构信息

Department of Pharmacy Services, University of Michigan Health Systems, Ann Arbor, Michigan.

Pharmacy Services, Mayo Clinic - St. Mary's Hospital, Rochester, Minnesota.

出版信息

J Adv Pract Oncol. 2016 Nov-Dec;7(7):764-778. doi: 10.6004/jadpro.2016.7.7.8. Epub 2016 Nov 1.

DOI:10.6004/jadpro.2016.7.7.8
PMID:29670812
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5902156/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/9c9ec124afdb/jadp-07-764-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/a0b031a31ac8/jadp-07-764-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/1f13dc5ba499/jadp-07-764-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/d509d7ace5c1/jadp-07-764-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/2ab7c6f1cd51/jadp-07-764-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/0761c0ec82a5/jadp-07-764-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/161853348865/jadp-07-764-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/9c9ec124afdb/jadp-07-764-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/a0b031a31ac8/jadp-07-764-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/1f13dc5ba499/jadp-07-764-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/d509d7ace5c1/jadp-07-764-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/2ab7c6f1cd51/jadp-07-764-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/0761c0ec82a5/jadp-07-764-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/161853348865/jadp-07-764-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2a3f/5902156/9c9ec124afdb/jadp-07-764-g07.jpg

相似文献

1
Chemoembolization With Drug-Eluting Beads for the Treatment of Hepatocellular Carcinoma.载药微球化疗栓塞术治疗肝细胞癌
J Adv Pract Oncol. 2016 Nov-Dec;7(7):764-778. doi: 10.6004/jadpro.2016.7.7.8. Epub 2016 Nov 1.
2
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma.药物洗脱微球与传统化疗栓塞术治疗不可切除肝细胞癌的对比
J Gastroenterol Hepatol. 2016 Mar;31(3):645-53. doi: 10.1111/jgh.13147.
3
CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.与传统经动脉化疗栓塞术相比，载药微球经导管动脉化疗栓塞术治疗肝细胞癌患者疗效更佳且安全性相当。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819830751. doi: 10.1177/1533033819830751.
4
Contrast-enhanced ultrasound evaluation of residual blood flow to hepatocellular carcinoma after treatment with transarterial chemoembolization using drug-eluting beads: a prospective study.使用载药微球经动脉化疗栓塞治疗后肝细胞癌残余血流的超声造影评估：一项前瞻性研究
J Ultrasound Med. 2015 May;34(5):859-67. doi: 10.7863/ultra.34.5.859.
5
Transarterial chemoembolization for treatment of hepatocellular carcinoma: A single center experience.经动脉化疗栓塞术治疗肝细胞癌：单中心经验
Turk J Gastroenterol. 2013;24(2):141-7. doi: 10.4318/tjg.2013.0709.
6
Transarterial chemoembolization with drug-eluting beads in hepatocellular carcinoma.肝细胞癌中使用载药微球的经动脉化疗栓塞术
World J Gastroenterol. 2016 Oct 28;22(40):8853-8861. doi: 10.3748/wjg.v22.i40.8853.
7
[Transcatheter arterial chemoembolization with doxorubicin eluting beads in the treatment of hepatocellular carcinoma].经动脉化疗栓塞联合阿霉素洗脱微球治疗肝细胞癌
Acta Med Port. 2011 Jan-Feb;24(1):29-36. Epub 2011 Feb 28.
8
Transarterial chemoembolization using drug eluting beads for the treatment of hepatocellular carcinoma: Now and future.使用载药微球的经动脉化疗栓塞术治疗肝细胞癌：现状与未来。
Clin Mol Hepatol. 2015 Dec;21(4):344-8. doi: 10.3350/cmh.2015.21.4.344. Epub 2015 Dec 24.
9
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis.药物洗脱微球与传统化疗栓塞术治疗不可切除肝细胞癌的Meta分析
Dig Liver Dis. 2016 Jun;48(6):571-7. doi: 10.1016/j.dld.2016.02.005. Epub 2016 Feb 21.
10
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma.射频消融联合载药微球经动脉化疗栓塞治疗单个大肝细胞癌
Dig Liver Dis. 2015 Mar;47(3):242-8. doi: 10.1016/j.dld.2014.12.007. Epub 2014 Dec 13.

引用本文的文献

1
X-ray Opaque Polymer Drug-Eluting Beads Loaded with Iodized Oil: Preparation and In Vitro and In Vivo Evaluations.负载碘化油的X射线不透性聚合物药物洗脱微球：制备及体内外评价
ACS Omega. 2024 Jul 8;9(29):31353-31358. doi: 10.1021/acsomega.3c09368. eCollection 2024 Jul 23.
2
CalliSpheres Drug-Eluting Bead Transcatheter Arterial Chemoembolization Presents With Better Efficacy and Equal Safety Compared to Conventional TACE in Treating Patients With Hepatocellular Carcinoma.与传统经动脉化疗栓塞术相比，载药微球经导管动脉化疗栓塞术治疗肝细胞癌患者疗效更佳且安全性相当。
Technol Cancer Res Treat. 2019 Jan 1;18:1533033819830751. doi: 10.1177/1533033819830751.

本文引用的文献

1
Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?经动脉化疗栓塞术与索拉非尼治疗中期肝细胞癌患者：是时候进入常规临床实践了吗？
Future Oncol. 2015;11(17):2371-3. doi: 10.2217/FON.15.173. Epub 2015 Aug 13.
2
Global cancer statistics, 2012.全球癌症统计数据，2012 年。
CA Cancer J Clin. 2015 Mar;65(2):87-108. doi: 10.3322/caac.21262. Epub 2015 Feb 4.
3
Survival outcomes in patients with advanced hepatocellular carcinoma treated with drug-eluting bead chemoembolization.
接受载药微球化疗栓塞治疗的晚期肝细胞癌患者的生存结局
AJR Am J Roentgenol. 2015 Feb;204(2):440-7. doi: 10.2214/AJR.14.12844.
4
Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.经动脉化疗栓塞治疗原发性肝癌和结直肠癌肝转移
Surg Oncol Clin N Am. 2015 Jan;24(1):149-66. doi: 10.1016/j.soc.2014.09.004. Epub 2014 Oct 7.
5
Survival, efficacy, and safety of small versus large doxorubicin drug-eluting beads TACE chemoembolization in patients with unresectable HCC.小剂量与大剂量多柔比星载药微球 TACE 化疗栓塞治疗不可切除 HCC 患者的生存、疗效和安全性。
AJR Am J Roentgenol. 2014 Dec;203(6):W706-14. doi: 10.2214/AJR.13.12308.
6
Treatment of hepatocellular carcinoma.肝细胞癌的治疗
Dig Dis. 2014;32(5):554-63. doi: 10.1159/000360501. Epub 2014 Jul 14.
7
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.随机对照试验：阿霉素洗脱微球与常规化疗栓塞治疗肝细胞癌的比较。
Br J Cancer. 2014 Jul 15;111(2):255-64. doi: 10.1038/bjc.2014.199. Epub 2014 Jun 17.
8
Transarterial chemoembolization and sorafenib in hepatocellular carcinoma.经动脉化疗栓塞术与索拉非尼治疗肝细胞癌
Expert Rev Anticancer Ther. 2014 Jul;14(7):831-45. doi: 10.1586/14737140.2014.920694. Epub 2014 May 22.
9
Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature.经动脉化疗栓塞术和放射性栓塞术治疗原发性肝癌和继发性肝癌：文献综述
J Med Imaging Radiat Oncol. 2014;58(3):341-52. doi: 10.1111/1754-9485.12163. Epub 2014 Mar 3.
10
Transarterial therapies for primary liver tumors.原发性肝癌的经动脉治疗
Surg Oncol Clin N Am. 2014 Apr;23(2):323-51. doi: 10.1016/j.soc.2013.11.002.